When to escalate to external review — and when to stop

What external review actually is

Under the Affordable Care Act, most non-grandfathered health plans must offer external review of adverse benefit determinations involving medical judgment. The review is conducted by an Independent Review Organization (IRO) that has no financial relationship with your insurer. Its decision is binding — if the IRO overturns the denial, your insurer must cover the service.

That binding nature is the reason external review matters. Internal appeals are the insurer reviewing its own decision; external review is somebody else deciding. Federal data and KFF analysis consistently show external review reverses a meaningful share of denials that made it past internal appeal. For the bigger comparison, our pillar on internal appeal vs. external review covers the procedural differences.

External review is conducted by an Independent Review Organization with no financial relationship to your insurer. Its decision is binding on the plan.

When external review is your best move

External review tends to work well when the dispute turns on clinical judgment that an outside specialist can re-evaluate on the same record. The clearest categories:

• Medical necessity denials. The insurer said the service wasn’t medically necessary. An IRO physician in the relevant specialty re-reads the clinical file and decides. This is the highest-volume category at external review.
• Experimental or investigational denials. The insurer said the treatment is unproven. The IRO evaluates current peer-reviewed literature, treatment guidelines, and FDA approval status. Strong category for cancer, rare-disease, and certain specialty drug denials.
• Prior authorization denials that turn on clinical criteria. The insurer said the criteria weren’t met. The IRO reassesses against the same criteria with fresh eyes — and sometimes a different clinical view.
• Rescissions and certain coverage determinations. Limited but real category; external review can address some rescission decisions.

When external review is the wrong tool

External review is not a general-purpose appeal. It is specifically about adverse determinations involving medical judgment. Cases that usually don’t belong at external review:

• Clear plan exclusions. Your plan explicitly says the service isn’t covered, the exclusion clearly applies, and there’s no medical-judgment overlay. The IRO can’t rewrite your contract.
• Eligibility disputes. Whether you were enrolled, whether premiums were paid, whether dependents qualify — these are administrative, not clinical.
• Coordination of benefits issues. Which insurer is primary versus secondary is typically resolved through claims correction, not external review.
• Pure billing or coding disputes. Wrong code, missing modifier, duplicate. These resolve with the provider’s billing office.
• Network status disputes without a clinical hook. If the question is purely whether a provider was in-network, external review usually isn’t the right path — surprise-billing protections under the No Surprises Act may apply instead.

State versus federal external review

Two systems exist, and the one that applies depends on your plan type and state:

1. State-run external review. Most states operate their own NAIC-compliant external review program. California uses Independent Medical Review through DMHC. Texas uses certified IROs through TDI. New York runs an External Appeal program through DFS. State programs often have well-developed consumer protections and clear forms.
2. Federally-administered external review. For plans not subject to a state external-review program (typically self-funded ERISA plans, plus residents of states that defer to the federal process), HHS administers external review through the NAIRO contractor system.

Your final internal denial letter must tell you which system applies and how to file. For state-specific guidance, see our California external review page or your applicable state. The CARC code on the original denial often signals which category the case belongs in — our CARC 197 page covers prior authorization, and CARC 55 covers experimental/investigational.

The decision tree

After an internal denial, walk through these questions in order:

1. Did the denial involve clinical judgment? If yes, external review is on the table. If no, look at alternatives like a state insurance department complaint or provider-side billing correction.
2. Is the deadline clock running? Federal external review usually has a 4-month window from final internal denial. Calendar the deadline immediately.
3. Is the situation urgent? If a standard 60-day timeline would jeopardize your health, file expedited external review — 72 hours. You can also run it in parallel with an expedited internal appeal. Our guide on expedited insurance appeals covers the timing.
4. Is the evidence complete? External reviewers decide on the documents in front of them. A treating-provider letter, current clinical notes, plan language citations, and (for medical necessity) peer support are the spine of a strong external review file.
5. If external review isn’t the right path: consider a state insurance department complaint, ERISA-related options for self-funded plans, or re-routing the issue through the provider’s billing office for administrative fixes.

When to stop

Sometimes the right call is to stop appealing. If the service is clearly excluded by plan language, the deadline has truly run, and no procedural error in the denial gives you a foothold, escalating further is mostly time spent. Resources are often better directed toward billing negotiation with the provider, hardship-discount programs, or pursuing the service under a different plan year. For a broader overview of the appeal landscape, the pillar on how to appeal a denied health insurance claim covers where each path fits.

Start with a free triage See pricing